Finally, Western blot and qPCR showed that treatment with berberine (40 μM), a natural isoquinoline alkaloid derived from Berberis genus plants, decreased the expression of Bcl2 protein but not mRNA in human colorectal cancer cell lines HT-29 and HCT-116 [104]. Here, BCL2 is linked to colorectal cancer.